IRON Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,252
Closed -$268K 110
2024
Q3
$268K Sell
2,252
-44
-2% -$5.87K 0.15% 81
2024
Q2
$328K Buy
2,296
+13
+0.6% +$1.72K 0.18% 74
2024
Q1
$293K Buy
2,283
+13
+0.6% +$1.55K 0.16% 75
2023
Q4
$235K Sell
2,270
-6
-0.3% -$593 0.13% 86
2023
Q3
$207K Buy
+2,276
New +$200K 0.12% 93

Other funds holding NVO

IRON Financial's NVO Position: Q4 2024 in Review

IRON Financial sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,252 shares — an estimated $268K sold.

IRON Financial first reported a position in NVO in Q3 2023 and held it in 5 quarters. The position peaked at $328K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • IRON Financial reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • IRON Financial sold 2,252 Novo Nordisk shares in Q4 2024, an estimated $268K.
  • IRON Financial first reported a position in Novo Nordisk in Q3 2023 and held it in 5 quarters.
  • IRON Financial's Novo Nordisk position peaked at $328K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on IRON Financial's 13F filing for Q4 2024, filed 22 Jan 2025.